This information was published on 2026-08-28T11:12 for IP Right Registration Published.
| Field | Value |
| (210) | 2491996 (IR 1813039) |
| (220) |
29 Apr 2024
|
| (300) |
US, 31 Oct 2023, 98248592
|
| (511) (510) |
Class 1
Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research. Class 5 Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; all of the aforementioned items not being for or including pharmaceutical intravenous natural (or canonical) amino acid solutions that provide nutritional support in healthcare settings. Class 40 Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use. Class 42 Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides. |
| (540) | SYNTEIN |
| (550) | Word |
| (730) |
Abiologics, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.